Compare, Analyse Pfizer with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   TEVA PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-21
TEVA PHARMA
Dec-13
PFIZER/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs5,8753,102-   
Low Rs3,8332,695-   
Sales per share (Unadj.) Rs489.31,780.3-  
Earnings per share (Unadj.) Rs108.8111.2-  
Cash flow per share (Unadj.) Rs132.7255.1-  
Dividends per share (Unadj.) Rs35.0097.36-  
Avg Dividend yield %0.73.4 21.5%  
Book value per share (Unadj.) Rs523.11,977.6-  
Shares outstanding (eoy) m45.75848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x9.91.6 609.3%   
Avg P/E ratio x44.626.1 171.2%  
P/CF ratio (eoy) x36.611.4 322.0%  
Price / Book Value ratio x9.31.5 633.1%  
Dividend payout %32.287.5 36.8%   
Avg Mkt Cap Rs m222,0632,457,911 9.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m3,6110-   
Avg. sales/employee Rs ThNM33,590.8-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,098.4-  
INCOME DATA
Net Sales Rs m22,3861,509,736 1.5%  
Other income Rs m8110-   
Total revenues Rs m23,1971,509,736 1.5%   
Gross profit Rs m7,124413,442 1.7%  
Depreciation Rs m1,094122,033 0.9%   
Interest Rs m15429,654 0.5%   
Profit before tax Rs m6,687261,755 2.6%   
Minority Interest Rs m01,189 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-171,828 0.0%   
Tax Rs m1,711-3,196 -53.5%   
Profit after tax Rs m4,97694,312 5.3%  
Gross profit margin %31.827.4 116.2%  
Effective tax rate %25.6-1.2 -2,095.8%   
Net profit margin %22.26.2 355.8%  
BALANCE SHEET DATA
Current assets Rs m19,2471,019,670 1.9%   
Current liabilities Rs m7,743889,239 0.9%   
Net working cap to sales %51.48.6 594.8%  
Current ratio x2.51.1 216.8%  
Inventory Days Days7591 82.7%  
Debtors Days Days296 2.2%  
Net fixed assets Rs m13,277493,113 2.7%   
Share capital Rs m4583,716 12.3%   
"Free" reserves Rs m23,4730-   
Net worth Rs m23,9301,677,031 1.4%   
Long term debt Rs m0771,962 0.0%   
Total assets Rs m32,5243,450,232 0.9%  
Interest coverage x44.59.8 452.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.70.4 157.3%   
Return on assets %15.83.6 439.0%  
Return on equity %20.85.6 369.8%  
Return on capital %28.64.9 579.7%  
Exports to sales %1.50-   
Imports to sales %2.30-   
Net fx Rs m-1710-   
CASH FLOW
From Operations Rs m4,273240,574 1.8%  
From Investments Rs m-4,688-85,245 5.5%  
From Financial Activity Rs m-15,711-288,585 5.4%  
Net Cashflow Rs m-16,126-133,256 12.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.32 Rs / USD

Compare PFIZER With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare PFIZER With: BAFNA PHARMA  VAISHALI PHARMA   RPG LIFE SCIENCES  AAYUSH FOOD & HERBS   DECIPHER LABS  



Today's Market

Sensex Sheds 427 Points, Nifty Ends Near 17,600; Bajaj Finserv, Tata Steel & Tech Mahindra Top Losers(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended on a weak note.

Related Views On News

PFIZER 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of PFIZER for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain (Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PFIZER SHARE PRICE


Jan 21, 2022 (Close)

TRACK PFIZER

MORE ON PFIZER

PFIZER - ZIM LABORATORIES COMPARISON

COMPARE PFIZER WITH

MARKET STATS